Queensland Numbered Acts
[Index]
[Table]
[Search]
[Search this Act]
[Notes]
[Noteup]
[Previous]
[Next]
[Download]
[Help]
PUBLIC HEALTH (MEDICINAL CANNABIS) ACT 2016 - SECT 26
Criteria for grant of clinical trial approval
26 Criteria for grant of clinical trial approval
(1) When considering an application for a clinical trial approval the chief
executive may have regard to the following— (a) whether the applicant is a
suitable person to hold the approval;
(b) any approval required for the
clinical trial under the Therapeutic Goods Act 1989 (Cwlth) ;
(c) whether the
medicinal cannabis to which the approval will apply has, or will be,
manufactured or imported in accordance with the applicable law of the
Commonwealth;
(d) any other information in the application for the approval;
(e) any other matters the chief executive reasonably considers relevant to
deciding the application.
(2) Without limiting subsection (1), the chief
executive may grant a clinical trial approval only if the chief executive is
satisfied— (a) the applicant is a suitable person to hold the approval; and
(b) the medicinal cannabis to which the approval will apply has, or will be,
manufactured or imported in accordance with the applicable law of the
Commonwealth.
AustLII: Copyright Policy
| Disclaimers
| Privacy Policy
| Feedback